Scarica l'app Stockscreener
9.19
0.88%
0.08
Dopo l'orario di chiusura:
9.25
0.06
+0.65%
Adma Biologics Inc Borsa (ADMA) Ultime notizie
2026-04-05 | ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ADMA | Press Release - Stockhouse
ADMA SEC FilingsAdma Biologics 10-K, 10-Q, 8-K Forms - Stock Titan
ADMA PE Ratio & Valuation, Is ADMA Overvalued - intellectia.ai
US High Growth Tech Stocks To Watch For Potential Expansion - Sahm
Stock Drop Alert: ADMA Biologics ($ADMA) Stock Plummets 29% after Channel Stuffing Claims DisclosedInvestors Notified of Securities Fraud Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Investors to Connect - ACCESS Newswire
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc. - ACCESS Newswire
ADMA (ADMA) COO reports 20,362-share RSU tax withholding, holds 446,238 shares - Stock Titan
ADMA Biologics gains after refuting short seller claims - MSN
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Investors to Connect | NDAQ:ADMA | Press Release - Stockhouse
ADMA Biologics Investigated for Securities Fraud After Plunge - National Today
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics, Inc. (ADMA) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
$ADMA Stock News: ADMA Biologics Investigated for Securities Fraud Following Channel Stuffing Claims – Investors Notified to Contact BFA Law - GlobeNewswire Inc.
Short seller report alleges ADMA Biologics financial misrepresentation - MSN
Trading the Move, Not the Narrative: (ADMA) Edition - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ADMA Investor Alert: ADMA Biologics Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Revenue Headwinds: Levi & Korsinsky - Sahm
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inqui - The National Law Review
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation – ADMA - Eagle-Tribune
ADMA Biologics Inc (ADMA) Stock Forecasts - finance.yahoo.com
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026? - Zacks Investment Research
ADMA Biologics Under Investigation for Securities Fraud - intellectia.ai
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Investors to Reach Out - ACCESS Newswire
Investor Notice: ADMA Biologics ($ADMA) Stock Dropped 29% After Culper Research Report AnnouncementInvestigation Pending - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential ... - Bluefield Daily Telegraph
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - finance.yahoo.com
ADMA Biologics Investigated for Securities Fraud After Stock Drop - National Today
ADMA Biologics Investigated for Securities Fraud After Plummeting Stock - National Today
ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop - PR Newswire
Adma Biologics (ADMA) Shares Fall as Overall Market Rises: Key Insights for Investors - Bitget
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Stockholders to Reach Out - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating - PR Newswire
2026-03-30 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Stockholders to Reach Out | NDAQ:ADMA | Press Release - Stockhouse
$ADMA Investor News: ADMA Biologics Faces Securities Fraud - globenewswire.com
ADMA Biologics (ADMA) soars 11.6% as firm denies short seller allegations - MSN
ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits
ADMA Biologics says short report contains misleading, inaccurate statements - MSN
ADMA’s Upward Candlesticks Face Off Against a 41.6% Price Decline — What Lies Ahead? - Bitget
Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Stockholders to Connect - ACCESS Newswire
2026-03-29 | Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Stockholders to Connect | NDAQ:ADMA | Press Release - Stockhouse
Did ADMA Biologics($ADMA) Mislead Investors about Channel Stuffing Issues? Investors with Losses Notified of Ongoing Securities Fraud Investigation - ACCESS Newswire
ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Rating Upgrade) - seekingalpha.com
ADMA Biologics Faces Increased Short Interest Amid Allegations - National Today
ADMA Biologics Inc (NASDAQ:ADMA) Short Interest Update - MarketBeat
Does ADMA Biologics’ (ADMA) Rebuttal to Short-Seller Claims Strengthen Its Management Credibility Narrative? - Yahoo Finance
ADMA stock drops 6% after Culper Research alleges channel stuffing - msn.com
ADMA Biologics extends selloff as Cantor downgrades after short report - MSN
5 Stocks Investors Are Tracking Now - Insider Monkey
ADMA Biologics (ADMA) Soars 11.6% as Firm Denies Short Seller Allegations - finance.yahoo.com
ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - The National Law Review
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over - GlobeNewswire
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research - StreetInsider
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):